He M, Xie W, Yuan Z, Chen J, et al. Comparing PD-L1 and PD-1 inhibitors plus bevacizumab combined with hepatic arterial interventional therapies in unresetable hepatocellular carcinoma: A single-center, real-world study. Int J Cancer 2025 Jan 20. doi: 10.1002/ijc.35341.
PMID: 39834172